Diagnostic performance of DCE-MRI, multiparametric MRI and multimodality imaging for discrimination of breast non-mass-like enhancement lesions.

OBJECTIVE

The aim of this study was to investigate and compare the diagnostic performance of dynamic contrast-enhanced (DCE)-MRI, multiparametric MRI (mpMRI), and multimodality imaging (MMI) combining mpMRI and mammography (MG) for discriminating breast non-mass-like enhancement (NME) lesions.

METHODS

This retrospective study enrolled 193 patients with 199 lesions who underwent 3.0 T MRI and MG from January 2017 to December 2019. The features of DCE-MRI, turbo inversion recovery magnitude (TIRM), and diffusion-weighted imaging (DWI) were assessed by two breast radiologists. Then, all lesions were divided into microcalcification and non-microcalcification groups to assess the features of MG. Comparisons were performed between groups using univariate analyses. Then, multivariate analyses were performed to construct diagnostic models for distinguishing NME lesions. Diagnostic performance was evaluated by using the area under the curve (AUC) and the differences between AUCs were evaluated by using the DeLong test.

RESULTS

Overall ( = 199), mpMRI outperformed DCE-MRI alone (AUC = 0.924 vs AUC = 0.884; = 0.007). Furthermore, MMI outperformed both mpMRI and MG (the microcalcification group [ = 140]: AUC = 0.997 vs. AUC = 0.978, = 0.018 and AUC = 0.997 vs. AUC = 0.912, < 0.001; the non-microcalcification group [ = 59]: AUC = 0.857 vs. AUC = 0.768, = 0.044 and AUC = 0.857 vs. AUC = 0.759, = 0.039).

CONCLUSION & ADVANCES IN KNOWLEDGE: DCE-MRI combined with DWI and TIRM information could improve the diagnostic performance for discriminating NME lesions compared with DCE-MRI alone. Furthermore, MMI combining mpMRI and MG showed better discrimination than both mpMRI and MG.